We found that, compared with those with FAK splicing variants, patients with SCLC and FAK splicing variants had a significantly worse prognosis (Fig. 7a, P = 0.029), suggesting that alternative FAK splicing variants may play a critical role in SCLC pathogenesis. The gene discussed is PTK2; the disease is small cell lung carcinoma.